FindTrial
Sign In

Homoeopathic management of anxiety and depression symptoms in type 2 diabetes patients using Hamilton scales: a randomized controlled trial

HOMOEOPATHIC MANAGEMENT OF EXPRESSIONS OF ANXIETY or DEPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING HAMILTON ANXIETY SCALE (HAM-A) OR HAMILTON DEPRESSION RATING SCALE (HAM D): A RANDOMIZED CONTROL TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105640
Enrollment
68
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Individualized Homoeopathic Treatment: Individualized homoeopathic medicines selected based on totality of symptoms and constitutional assessment, administered orally in appropriate pot

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed T2DM patients aged 18-65 years with - Expressions of anxiety within mild to moderate as assessed by Hamilton Anxiety Rating Scale (HAM-A) score 1 to 24 with duration of 2 weeks to 6 months. - Expressions of Depression within mild to moderate as assessed by Hamilton Depression Rating Scale (HAM-D) score between 8 to 24 with duration of 2 weeks to 3 months. - Who are on standard of care for management of diabetes for past 3 months, with HbA1c levels 6.5 % - 9.5% - Not currently undergoing other forms of psychological or psychiatric treatment. - Both Genders willing to give written consent for the part of this study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in severity of anxiety or depression from baseline to 12 months, assessed using: Hamilton Anxiety Rating Scale (HAM-A) score OR Hamilton Depression Rating Scale (HAM-D) score (Comparison between intervention and control group)Timepoint: Glycaemic Control: Fasting blood sugar (FBS) levels monthly once for 1st 3 months after allocation, followed by once in 3 months. Postprandial blood sugar (PPBS) levels- monthly once for 1st 3 months after allocation, followed by once in 3 months. HbA1c levels - once in 6 months. Anxiety or Depression Scores: HAM-A scores for anxiety (after 3rd, 6th ,9th and 12th month). Or HAM-D scores for depression (after 3rd, 6th, 9th and 12th month).—

Secondary

MeasureTime frame
Change in glycaemic control parameters: Fasting Blood Sugar (FBS) Post-Prandial Blood Sugar (PPBS) HbA1c Correlation between change in HAM-A / HAM-D scores and: FBS PPBS HbA1c Requirement/modification of oral hypoglycaemic agents during study period.Timepoint: from baseline to 12 months—

Countries

India

Contacts

Public ContactDr Siddesha G

Father Muller Homoeopathic Medical College and Hospital

drsiddeshag@gmail.com08660861093

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026